MKI67 and neoplasm: Eventually, genetic testing will complete our knowledge and clarify some doubts, but in everyday practice, it is possible to assess stratification risk with greater accuracy using accessible data like tumor size, histological parameters (included in PASS score), and additional immunohistochemical markers (proliferative index Ki67, S100, and SDHB).